文献速递胰腺与胆道疾病消化内镜

超声内镜引导下经乳头内镜与经皮胆囊引流治疗急性胆囊炎的比较:系统评价与网状Meta分析

Comparison of EUS-guided endoscopic transpapillary and percutaneous gallbladder drainage for acute cholecystitis: a systematic review with network meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2020-09-25

该系统评价与网状Meta分析纳入10项比较研究共1267例不适合手术的急性胆囊炎患者,比较经皮、内镜经乳头和超声内镜引导三种胆囊引流方式。结果显示三种方式各有优劣,经皮引流的技术与临床成功率排名最高但再干预和计划外再入院风险最高,内镜经乳头引流死亡率最低,超声内镜引导引流复发胆囊炎风险最低。在具备内镜胆囊引流专长的中心,内镜技术较经皮引流结局更优。

要点

  • 经皮引流的技术成功与临床成功可能性最高,但再干预和计划外再入院风险也最高。
  • 内镜经乳头引流的死亡率最低,但技术成功与临床成功可能性最低。
  • 超声内镜引导引流的复发胆囊炎风险最低,在具备专长的中心结局优于经皮引流。

核心结论

  • 三种胆囊引流方式各有优缺点,技术选择取决于可用的专长。
  • 在具备内镜胆囊引流专长的中心,内镜技术较经皮引流结局更优。

研究设计与样本

  • 系统评价与网状Meta分析,纳入10项比较研究,共1267例患者(超声内镜引导472例、经皮493例、内镜经乳头302例)。
  • 检索评估两种或全部三种方式治疗胆囊切除高风险急性胆囊炎患者疗效的比较研究。
  • 主要结局为技术成功、临床成功和术后不良事件;次要结局为再干预、计划外再入院、复发胆囊炎和死亡率。
  • 注册号:CRD42020181972。

主要发现

  • 网状排名估计中,经皮引流与超声内镜引导引流的技术成功可能性最高(超声内镜引导 vs 经皮 vs 内镜经乳头:2.00 vs 1.02 vs 2.98)。
  • 网状排名估计中,经皮引流与超声内镜引导引流的临床成功可能性最高(超声内镜引导 vs 经皮 vs 内镜经乳头:1.48 vs 1.55 vs 2.98)。
  • 超声内镜引导引流的复发胆囊炎风险最低(超声内镜引导 vs 经皮 vs 内镜经乳头:1.089 vs 2.02 vs 2.891)。
  • 经皮引流的再干预风险最高(超声内镜引导 vs 经皮 vs 内镜经乳头:1.81 vs 2.99 vs 1.199),计划外再入院风险也最高(超声内镜引导 vs 经皮 vs 内镜经乳头:1.582 vs 2.944 vs 1.474)。
  • 内镜经乳头引流的死亡率最低(超声内镜引导 vs 经皮 vs 内镜经乳头:2.62 vs 2.09 vs 1.29)。

关键数值与推荐

  • 共纳入10项研究、1267例患者:超声内镜引导472例、经皮493例、内镜经乳头302例。
  • 技术成功排名:超声内镜引导2.00、经皮1.02、内镜经乳头2.98。
  • 临床成功排名:超声内镜引导1.48、经皮1.55、内镜经乳头2.98。
  • 复发胆囊炎排名:超声内镜引导1.089、经皮2.02、内镜经乳头2.891。
  • 再干预排名:超声内镜引导1.81、经皮2.99、内镜经乳头1.199;计划外再入院排名:超声内镜引导1.582、经皮2.944、内镜经乳头1.474;死亡率排名:超声内镜引导2.62、经皮2.09、内镜经乳头1.29。

临床怎么用

  • 在具备内镜胆囊引流专长的中心,内镜技术较经皮引流结局更优,技术选择取决于可用的专长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The optimal method of gallbladder drainage (GBD) for acute cholecystitis in nonsurgical candidates is uncertain. The aim of the current study was to conduct a network meta-analysis comparing the 3 methods of GBD (percutaneous [PT], endoscopic transpapillary [ETP], and EUS-guided). METHODS: A comprehensive literature search for all comparative studies assessing the efficacy of either 2 or all modalities used for treatment of acute cholecystitis in patients at high risk for cholecystectomy was performed. Primary outcomes of technical and clinical success and postprocedure adverse events were assessed. Secondary outcomes were reintervention, unplanned readmissions, recurrent cholecystitis, and mortality. RESULTS: Ten studies were identified, comprising 1267 patients (472 EUS-GBD, 493 PT-GBD, and 302 ETP-GBD). In the network ranking estimate, PT-GBD and EUS-GBD had the highest likelihood of technical success (EUS-GBD vs PT-GBD vs ETP-GBD: 2.00 vs 1.02 vs 2.98) and clinical success (EUS-GBD vs PT-GBD vs ETP-GBD: 1.48 vs 1.55 vs 2.98). EUS-GBD had the lowest risk of recurrent cholecystitis (EUS-GBD vs PT-GBD vs ETP-GBD: 1.089 vs 2.02 vs 2.891). PT-GBD had the highest risk of reintervention (EUS-GBD vs PT-GBD vs ETP-GBD: 1.81 vs 2.99 vs 1.199) and unplanned readmissions (EUS-GBD vs PT-GBD vs ETP-GBD: 1.582 vs 2.944 vs 1.474), whereas ETP-GBD was associated with the lowest rates of mortality (EUS-GBD vs PT-GBD vs ETP-GBD: 2.62 vs 2.09 vs 1.29). CONCLUSIONS: The 3 modalities of GBD have their respective advantages and disadvantages. Selection of technique will depend on available expertise. In centers with expertise in endoscopic GBD, the techniques are preferred over PT-GBD with improved outcomes. (Clinical trial registration number: CRD42020181972.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Podboy A, Yuan J, Stave CD, et al. Comparison of EUS-guided endoscopic transpapillary and percutaneous gallbladder drainage for acute cholecystitis: a systematic review with network meta-analysis. Gastrointest Endosc. 2020. PMID: 32987004. doi:10.1016/j.gie.2020.09.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。